View in EDS

Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report.

Saved in:
Bibliographic Details
Title: Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report.
Authors: Torasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Shiraishi K; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Goto N; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Ueno T; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Ichikawa H; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan., Kohsaka S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan., Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Source: JTO clinical and research reports [JTO Clin Res Rep] 2024 Feb 28; Vol. 5 (4), pp. 100657. Date of Electronic Publication: 2024 Feb 28 (Print Publication: 2024).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38706977
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Torasawa+M%22">Torasawa M</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+T%22">Yoshida T</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shiraishi+K%22">Shiraishi K</searchLink>; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+N%22">Goto N</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ueno+T%22">Ueno T</searchLink>; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ichikawa+H%22">Ichikawa H</searchLink>; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yagishita+S%22">Yagishita S</searchLink>; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kohsaka+S%22">Kohsaka S</searchLink>; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+Y%22">Goto Y</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yatabe+Y%22">Yatabe Y</searchLink>; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hamada+A%22">Hamada A</searchLink>; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Mano+H%22">Mano H</searchLink>; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohe+Y%22">Ohe Y</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769967%22">JTO clinical and research reports</searchLink> [JTO Clin Res Rep] 2024 Feb 28; Vol. 5 (4), pp. 100657. <i>Date of Electronic Publication: </i>2024 Feb 28 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101769967 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3643 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663643%22">26663643 </searchLink><i>NLM ISO Abbreviation: </i>JTO Clin Res Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38706977
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtocrr.2024.100657
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100657
    Titles:
      – TitleFull: Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Torasawa M
      – PersonEntity:
          Name:
            NameFull: Yoshida T
      – PersonEntity:
          Name:
            NameFull: Shiraishi K
      – PersonEntity:
          Name:
            NameFull: Goto N
      – PersonEntity:
          Name:
            NameFull: Ueno T
      – PersonEntity:
          Name:
            NameFull: Ichikawa H
      – PersonEntity:
          Name:
            NameFull: Yagishita S
      – PersonEntity:
          Name:
            NameFull: Kohsaka S
      – PersonEntity:
          Name:
            NameFull: Goto Y
      – PersonEntity:
          Name:
            NameFull: Yatabe Y
      – PersonEntity:
          Name:
            NameFull: Hamada A
      – PersonEntity:
          Name:
            NameFull: Mano H
      – PersonEntity:
          Name:
            NameFull: Ohe Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 02
              Text: 2024 Feb 28
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-3643
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: JTO clinical and research reports
              Type: main
ResultId 1